Gulnara Mamyrova

发表

Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity

P. Blackshear, M. Turner, S. Bauer, 2008, Medicine.

Parents' perception of self-advocacy of children with myositis: an anonymous online survey

P. White, L. Rider, A. Huber, 2011, Pediatric rheumatology online journal.

Gender bias in diagnosing fibromyalgia.

J. Katz, Gulnara Mamyrova, O. Guzhva, 2010, Gender medicine.

Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis

S. Eyre, S. Raychaudhuri, J. Bowes, 2022, Human molecular genetics.

Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.

Sharon Adams, James D Malley, J. Malley, 2006, Arthritis and rheumatism.

Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis

M. van Brussel, S. Adams, I. Targoff, 2015, Arthritis & rheumatology.

The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies

J. Malley, M. Rice, I. Targoff, 2013, Medicine.

Long-term outcomes in Juvenile Myositis patients.

S. Simmens, I. Targoff, F. Miller, 2020, Seminars in arthritis and rheumatism.

Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy

P. Lachenbruch, I. Targoff, F. Miller, 2013, Arthritis care & research.

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies

M. Rice, I. Targoff, F. Miller, 2013, Medicine.

Medications received by patients with juvenile dermatomyositis.

M. Ward, W. Warren‐hicks, I. Targoff, 2018, Seminars in arthritis and rheumatism.

A novel autoantibody to a 155-kd protein is associated with dermatomyositis.

I. Targoff, F. Miller, L. Rider, 2006, Arthritis and rheumatism.

Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.

D. Kleiner, F. Miller, L. Rider, 2007, Arthritis and rheumatism.

Parvovirus B19 and onset of juvenile dermatomyositis.

K. Brown, L. Rider, Gulnara Mamyrova, 2005, JAMA.

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

J. Lamb, H. Nagaraja, A. Payton, 2022, Annals of the Rheumatic Diseases.

Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis

I. Targoff, F. Miller, J. Soep, 2018, Rheumatology.

Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies

I. Targoff, F. Miller, L. Rider, 2010, Rheumatology.

Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

Glinda S Cooper, G. Cooper, F. Miller, 2008, Arthritis and rheumatism.

HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies.

M. Carrington, J. Malley, S. Chanock, 2006, Arthritis and rheumatism.

Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.

I. Targoff, F. Miller, L. Rider, 2020, Rheumatology.

Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies

P. Lachenbruch, I. Targoff, F. Miller, 2014, Arthritis care & research.

Environmental factors associated with disease flare in juvenile and adult dermatomyositis

F. Miller, L. Pachman, L. Rider, 2017, Rheumatology.

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy

L. Rider, A. Ehrlich, R. Curiel, 2023, Arthritis & rheumatology.

Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity

P. Blackshear, M. Turner, S. Bauer, 2008, Medicine.